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Caveolae are specialized invaginations of the plasma
membrane found in numerous cell types. They have
been implicated as playing a role in a variety of phys-
iological processes and are typically characterized
by their association with the caveolin family of
proteins. We show here by means of targeted gene
disruption in mice that a distinct caveolae-associ-
ated protein, Cavin/PTRF, is an essential component
of caveolae. Animals lacking Cavin have no morpho-
logically detectable caveolae in any cell type exam-
ined and have markedly diminished protein expres-
sion of all three caveolin isoforms while retaining
normal or above normal caveolin mRNA expression.
Cavin-knockout mice are viable and of normal weight
but have higher circulating triglyceride levels, signif-
icantly reduced adipose tissue mass, glucose intol-
erance, and hyperinsulinemia—characteristics that
constitute a lipodystrophic phenotype. Our results
underscore the multiorgan role of caveolae in meta-
bolic regulation and the obligate presence of Cavin
for caveolae formation.
INTRODUCTION
Caveolae are 50–100 nm invaginations of cell-surface mem-
branes that have been extensively studied for their possible func-
tion in signal transduction, membrane, and lipid trafficking. Their
numbers are especially abundant in endothelial cells, adipocytes,
and skeletal muscle (Parton and Simons, 2007; Pilch et al., 2007).
Caveolae require the expression of caveolins, a family of 22–
24 kD integralmembrane proteins consisting of caveolin-1 (Roth-
berg et al., 1992) (Cav1), which is predominantly expressed in ad-
ipocytes, fibroblasts, and endothelial cells (Parton and Simons,
2007; Pilch et al., 2007); Cav2, which is expressed in the same
cells that express Cav1 (Scherer et al., 1996); and Cav3, which310 Cell Metabolism 8, 310–317, October 8, 2008 ª2008 Elsevier Incis specifically expressed in skeletal, cardiac, and certain vascular
smooth-muscle beds (Tang et al., 1996; Way and Parton, 1995).
Under most experimental conditions, the ectopic expression of
Cav1 or Cav3 in caveolin-deficient cultured cells appears to be
sufficient for the formation of morphologically defined caveolae,
whereas ectopic expression of Cav2 is insufficient in this regard
and requires the coexpression of Cav1, with which it forms
hetero-oligomers in caveolae (Parton et al., 2006). Thus, the ac-
cepted paradigm is that caveolins are the sole or major structural
component of caveolae whose expression is necessary and suf-
ficient for their biogenesis. However, recent results from several
labs have identified Cavin (also known as PTRF for polymerase
I and transcript release factor, see Jansa et al., [1998]) as an
abundant peripheral membrane protein that is resident on the cy-
toplasmic face of caveolae (Aboulaich et al., 2004; Pilch et al.,
2007; Vinten et al., 2001). It is detected only in this plasma mem-
branedomainwhen visualized by immunoelectronmicroscopy of
gold-labeled anti-Cavin antibody (Vinten et al., 2005, 2001).
Moreover, the distribution of Cavin in rodents coincides with
those tissues that express both Cav1 and Cav3 (Vinten et al.,
2001).We and others have recently shown that over- or underex-
pression of Cavin in cultured cells leads to a parallel change in
Cav1 protein (Hill et al., 2008; Liu and Pilch, 2008) and caveolae
abundance (Hill et al., 2008). Thus, we hypothesized that Cavin
may be of physiological importance and a requisite protein
component of caveolae.
Specific biochemical and physiological roles for caveolae
have been difficult to ascribe with certainty, and many aspects
of their putative functions are controversial. However, mice
and humans deficient in their expression display numerous ab-
normalities that underscore their physiological importance (Le
Lay and Kurzchalia, 2005). Cav3 deficiency causes limb girdle
muscular dystrophy and rippling muscle disease in humans
and in mice (Betz et al., 2001; McNally et al., 1998; Minetti
et al., 1998; Vorgerd et al., 2001; Woodman et al., 2004), and
very recently, Cav1 deficiency in humans has been shown to
cause a type X lipodystrophy (Cao et al., 2008; Kim et al.,
2008). Deficiencies of caveolae in mice have also been shown
to play a role in additional pathologies including cardiovascular.
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2004).
Thus, to address the role of Cavin in vivo, we generated knock-
outmice lacking this protein. The resultant animals lack caveolae
in all tissues examined, underscoring a previously unrecognized
obligatory role for Cavin in Cav3-dependent caveolae formation
in skeletal muscle. Cavin-deficient mice have a uniquemetabolic
phenotype of reduced adipose tissue content and hyperlipid-
emia while expending less energy than their wild-type counter-
parts, apparently due to an inability to maintain equivalent phys-
ical activity. Consistent with the observed reduced fat mass, the
RNA levels are diminished for important adipocyte genes such
as the adipokines leptin and adiponectin. The observed dyslip-
idemia is also consistent with our in vitro data showing that
caveolin expression allows enhanced fatty acid partitioning
into cells (Meshulam et al., 2006). In addition to hyperlipidemia,
Cavin null mice exhibit glucose intolerance, hyperinsulinemia,
and a reduction in proteins associated with insulin signaling in
adipocytes and skeletal muscle. Taken together, impairment of
these processes causes a lipodystrophic and insulin-resistant
phenotype not unlike that very recently described for humans
deficient in Cav1 (Cao et al., 2008; Kim et al., 2008).
RESULTS
Generation of Cavin Null Mice
We replaced part of exon 1 of the Cavin gene (Ptrf) with a lacZ/
neo fusion cassette as shown in Figure 1A. The resultant expres-
sion of b-galactosidase was observed in muscle and endothelial
cells but was absent in liver (data not shown), consistent with the
known tissue distribution of Cavin protein (Vinten et al., 2001)
(see also Figure 2D). Analyses of genomic DNA by Southern
blot (Figure 1B), RNAbyPCR, (Figure 1C), and protein bywestern
blot (Figure 1D), confirmed the gene disruption and absence of
Cavin gene products in mice homozygous for the targeted allele
(Cavin/). Mice heterozygous for the targeted allele (Cavin/+)
were grossly normal and exhibited reduced amounts of Cavin
and Cav1 protein (Figure 1D). Homozygous animals are viable
and fertile but exhibit a number of metabolic abnormalities
(see below). In all subsequent studies, gender-, strain-, and
age-matched homozygous knockout animals were compared
to wild-type controls.
Cavin-Deficient Mice Lack Caveolae
Analysis of selected tissues from homozygousCavin null mice by
electron microscopy revealed that caveolae are completely ab-
sent from lung epithelium (Figure 2A), intestinal smooth muscle
(Figure 2B), and skeletal muscle (Figure 2C), as well as in endo-
thelial cells from all of these tissues. Caveolae were abundantly
present in these same tissues in wild-type mice (Cavin+/+) (Fig-
ures 2A–2C, left-hand panels). The absence of caveolae in
both lung epithelium and skeletal muscle is particularly notable
because different caveolin isoforms—Cav1 and Cav3, respec-
tively—are required for caveolae formation in these tissues (Par-
ton and Simons, 2007). Thus, Cavin is required for the formation
and/or stabilization of morphologically defined caveolae in all
tissues, regardless of the caveolin isoforms expressed.
Ablation of Cavin Reduces Expression of All Caveolin
Isoforms
At the protein level, the amount of caveolin was markedly re-
duced in all tissues examined from Cavin- knockout mice,
Figure 1. Generation ofCavin-Knockout Mice (Generated
Using a Previously Described Strategy Involving LacZ
Insertion [Yang et al., 2006])
(A) Schematic representation of the structure of the targeting vec-
tor and restriction enzyme sites of theCavin gene locus before and
after homologous recombination. Exon 1 in Cavin gene was
replaced by the gene encoding prokaryotic b-galactosidase,
designated here as lacZ.
(B) Genotype analysis by Southern blotting of offspring from Cavin
heterozygote (Cavin+/) mice intercrossed to generate homozy-
gote (Cavin/) mice is described in the Experimental Procedures.
Probing of EcoRI- and NdeI-digested genomic DNA revealed
8.4 kb and 5.3 kb fragments for wild-type and knockout genes,
respectively.
(C) PCR analysis was also devised as a 3-primer PCR-based
screening strategy. The common forward primer (p1) was derived
from theCavin promoter region before the recombination site, and
the wild-type specific reverse primer was derived from Cavin exon
1 (p2). The knockout-specific reverse primer was derived from the
lacZ cassette (p3). Primer sequences are provided in the Supple-
mental Experimental Procedures.
(D) Total protein from lung and adipocytes of wild-type (Cavin+/+),
heterozygote (Cavin+/), and knockout (Cavin/) mice was
examined by western blotting with anti-Cavin, anti-Cav1, and
anti-tubulin antibodies. See Supplemental Experimental Proce-
dures for details.Cell Metabolism 8, 310–317, October 8, 2008 ª2008 Elsevier Inc. 311
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Cavin Is an Essential Component of CaveolaeFigure 2. The Absence of Cavin Leads to Global Loss of Caveolae, Downregulation of Protein, and Upregulation of mRNA Expression Levels
for Caveolin Isoforms
(A–C) Electron micrographs of lung (A), smooth muscle (B), and skeletal muscle (C) tissues in wild-type (Cavin+/+) and Cavin-knockout mice (Cavin/). Analysis
was performed on 8-week-old male Cavin+/+ or Cavin/ mice of identical strain. The caveolae from wild-type mice showed the normal small invaginations
(arrows). The caveolae structures have disappeared from lung, skeletal muscle, and smooth muscle.
(D) Whole cell lysates from wild-type (Cavin+/+) and Cavin-knockout mice (Cavin/) (10-week-old strain-matched males) from the indicated tissues were pre-
pared in RIPA buffer. Protein (10–50 mg) was subjected to SDS-PAGE and immunoblotted with the indicated antibodies. The abbreviations Ad, Lu, Li, Br, He,312 Cell Metabolism 8, 310–317, October 8, 2008 ª2008 Elsevier Inc.
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abundant. It is again notable that Cav3 protein was virtually ab-
sent from heart and skeletal muscle (Figure 2D). Note that the
expression of Cav1 in these tissues from wild-type mice
(Figure 2D) is due to its presence in vascular cells not in myo-
cytes. As expected, Cav2 protein expression is reduced in the
Cavin null mice to essentially the same magnitude as Cav1, al-
though there is some variation in their ratio depending on the
Figure 3. Analysis of Metabolic Parameters
in Cavin Null and Wild-Type Mice
(A–C) Body weight, body composition, plasma insulin,
triglyceride, free fatty acid, adiponectin, and leptin levels
were measured in Cavin+/+ and Cavin/ mice as de-
scribed in Experimental Procedures. Mice were individu-
ally housed in metabolic chambers under fed and fasted
conditions, and oxygen consumption and carbon dioxide
production were measured for determination of (B) respi-
ratory-exchange ratio (RER) and (C) basal metabolic rate.
(D) Infrared beam breaks were used to quantify ambula-
tory activity.
(E) Glucose tolerance was assessed in Cavin+/+ and
Cavin/ mice, and values are expressed relative to basal
concentrations. Results are presented as means ± stan-
dard error. The statistical significance of differences was
determined by Student’s t test. The effects of group and
time were determined by two-way analysis of variance.
When group effects were significant (p < 0.05), Tukey-
Kramer subanalyses were performed to identify statisti-
cally significant differences between Cavin+/+ and
Cavin/ mice (4 males and 4 females per group, *p <
0.05, **p < 0.01, ***p < 0.001).
tissue. There were no differences in total actin
and tubulin levels between wild-type and
knockout animals (Figure 2D), similar to our re-
sults obtained by knocking down Cavin in cul-
tured adipocytes (Liu and Pilch, 2008). There
was also no change in transferrin receptor
(Tf-R) expression, as would be expected for
a plasma membrane marker known to be ab-
sent from caveolae (Liu and Pilch, 2008), nor
was there any change in flotillin expression,
a marker for noncaveolae lipid-raft domains
(Bickel et al., 1997). Interestingly, the expres-
sion of Cav1 and Cav2 mRNAs in adipocytes
from Cavin null mice was slightly increased
and was markedly higher in lung, as was
Cav3 expression in skeletal muscle, all as com-
pared to wild-type animals (Figure 2E). Thus, in
selected tissues, caveolin gene expression is
significantly increased under these circum-
stances, a possible compensatory response to the lack of
caveolae.
Dyslipidemia and Glucose Intolerance
in Cavin-Deficient Mice
Given the abnormalities observed in caveolin-deficient mice and
humans, we next measured a number of metabolic parameters
associated with carbohydrate and lipid metabolism (Figure 3A).Mu, St, SB, Ki, Sp, and Te, represent adipocytes, lung, liver, brain, heart, muscle (mixed hind-limb skeletal), stomach, small bowel, kidney, spleen and testis,
respectively.
(E) Quantitative RT-PCR (see Supplemental Experimental Procedures) was performed in adipocytes, lung, and muscle tissue by amplification with primers spe-
cific for Cav1,Cav2, and Cav3. Data were normalized to 18S rRNA and expressed as fold change relative to the mRNA levels in wild-type samples. The statistical
significance of differences between wild-type and Cavin-knockout mice (asterisks) was determined with Student’s t test, *p < 0.01. Each result represents the
average value and SE of at least three independent experiments.Cell Metabolism 8, 310–317, October 8, 2008 ª2008 Elsevier Inc. 313
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same weight, but they display a leaner body mass than wild-
type animals. Moreover, the knockout mice have significantly el-
evated serum triglycerides and free fatty acids, as well as dra-
matically increased levels of insulin. They also exhibit reduced
leptin and adiponectin expression and together, these parame-
ters are characteristic of certain congenital lipodystrophies
(Agarwal and Garg, 2006) and insulin resistance. Consistent
with this interpretation, the animals have an impaired whole-
body glucose tolerance (Figure 3E), as compared to gender-
and age-matched wild-type animals. Interestingly, they display
a lower resting metabolic rate (Figure 3C) and decreased habit-
ual physical activity (Figure 3D) with equivalent utilization of fuel
sources (Figure 3B). Thus, the lean phenotype of the Cavin null
mice and reduced metabolic capacity despite hyperlipidemia
most likely results from the reduced capacity for physical activity
that these animals display.
Insulin Action Is Impaired in Cavin Null Mice
Glucose intolerance is associated with insulin resistance and
an inability of normal circulating insulin levels to clear blood
glucose, primarily into skeletal muscle (Petersen and Shul-
man, 2002). In addition, since insulin-stimulated glucose
transport is required for triglyceride formation in adipocytes,
reduced insulin action in fat cells also contributes to insulin
resistance (Abel et al., 2001). Accordingly, we measured the
level and activity of several proteins involved in insulin action
in these tissues, namely Glut4 (Figure 4A), the insulin receptor
beta subunit (Figure 4B), and Akt2 (Figure 4C), the ultimate
kinase target of insulin signaling to glucose transport (Ng
et al., 2008). Glut4 levels were slightly diminished in adipo-
cytes (75%) and muscle (60%) compared to wild-type ani-
mals. As expected, transferrin receptors were unchanged in
null versus wild-type mice. Insulin-receptor levels were mark-
edly reduced in fat, less so in muscle, and not at all in liver.
Insulin-dependent Akt phosphorylation (S473) in fat, muscle,
Figure 4. Glut4 Expression Is Reduced and Insulin
Signaling Is Impaired in Cavin Null Mice
(A–C) After insulin injection (i.p. 0.75 U/kg), animals were sacri-
ficed, and whole cell lysates of wild-type (Cavin+/+) and Cavin-
knockout mice (Cavin/) (16-week-old strain-matched males)
from adipocyte, muscle, and liver tissues were prepared in RIPA
buffer. Representative western blots and quantitative bar graphs
are shown for the detection of (A) Glut4, (B) IR-beta protein levels,
and (C) total Akt and Akt S473 phosphorylation levels. The statis-
tical values are displayed as means and SE of three independent
experiments (*p < 0.05, **p < 0.01, ***p < 0.001).
and liver was significantly reduced in the Cavin
null mice as compared to wild-type animals
(Figure 4C), consistent with the overall insulin-resis-
tant phenotype. Glut4 is the transporter isoform that
is responsible for insulin-dependent glucose uptake
in fat and muscle (Pilch, 2008); therefore, a reduction
in insulin signaling together with diminished Glut4
levels can easily account for the observed dyslipi-
demia, glucose intolerance, and insulin resistance seen for
Cavin null mice.
DISCUSSION
Since the discovery that caveolin (now Cav1) is a protein compo-
nent of caveolae (Rothberg et al., 1992), the scientific community
has been intensely interested in these structures, and this inter-
est is underscored by the more recent revelations of human pa-
thology due to ‘‘caveolinopathies’’ (Betz et al., 2001; Cao et al.,
2008; Kim et al., 2008; Le Lay and Kurzchalia, 2005; McNally
et al., 1998; Minetti et al., 1998; Vorgerd et al., 2001; Woodman
et al., 2004). Despite this robust research activity, there has been
little consensus as to how caveolae function, and previous hy-
potheses, such as their role as a general scaffold for transmem-
brane signal-transduction pathways (Shaul and Anderson,
1998), have been called into question by the relatively normal
signaling seen in Cav1-knockout mice. One aspect of caveolae
biology, however, that is supported by a variety of recent studies
from numerous groups is a role in adipocytes for lipid storage
and release (Pilch et al., 2007). Our current study further supports
this hypothesis. Thus, Cav1 has been found in association with
lipid droplets (Liu et al., 2002, 2004; Parton and Simons, 2007;
van Meer, 2001) and has been postulated to traffic to these
structures from the cell surface (Le Lay et al., 2006). Ectopic
Cav1 expression in HEK293 cells enhances their ability to
move exogenously added free fatty acids to the cytosol (Meshu-
lam et al., 2006) and also enhances the ability of these cells to
store triglyceride (T. Meshulam and P.P., unpublished data).
We have suggested that caveolins function in this regard by their
ability to form detergent-resistant membranes domains that
‘‘buffer’’ high fatty acid concentrations (Meshulam et al., 2006).
This can protect cells against the potential cytotoxic effects of
high levels of fatty acids, which are themselves mild detergents.
The lipodystrophy we see in Cavin-deficient mice, which is very
similar to that recently reported for Cav1-deficient humans314 Cell Metabolism 8, 310–317, October 8, 2008 ª2008 Elsevier Inc.
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hypothesis.
Our data show that the absence of Cavin eliminates caveolae,
thus impairing the ability of adipocytes to store triglycerides,
which in turn leads to the observed increase in circulating lipids,
glucose intolerance, and insulin resistance. Because the animals
have a reduced respiratory capacity and are less active, the con-
centration of circulating lipids remains high. Elevated levels of
fatty acids correlate with insulin resistance in numerous animal
models as well as in humans (Boden, 1997; Kraegen et al.,
2001), and this is also the situation in the Cav1-deficient lipo-
dystrophic patients (Cao et al., 2008; Kim et al., 2008). Thus,
while there are likely to be multiple molecular mechanisms of in-
sulin resistance (Hoehn et al., 2008; Muoio and Newgard, 2008),
reduced insulin signaling and Glut4 levels in muscle—such
as those we observe in the Cavin null mice—are one such
mechanism.
How do Cavin null animals compare with Cav1 and Cav3 null
mice regarding metabolic parameters? Cav1 null mice of an
age comparable to those in the present study (8–12 weeks)
have a normal respiratory capacity, normal basal insulin, and
normal glucose levels (Razani et al., 2002). At this age, they do
have hypertriglyceridemia with normal free fatty acid levels, but
they are not glucose intolerant. Cav1 null mice go on to show
adipocyte abnormalities that are revealed at >6 months of age,
at which time they are significantly leaner and are more resistant
to diet-induced obesity than their wild-type littermates (Razani
et al., 2002). Thus, the Cav1-deficient phenotype is significantly
milder than that we see for Cavin deficiency, where metabolic
defects are observed at a much younger age. Cav3 null animals,
on the other hand, are fatter than wild-type mice, even at
8–9 weeks, and they do exhibit impaired glucose tolerance and
insulin resistance without an increase in circulating lipids
(Capozza et al., 2005). They also have a reduced insulin signaling
capacity similar to what we show here. Thus, the Cav3-deficient
animals also differ significantly from the Cavin nulls, and al-
though double Cav1/3-knockout animals have also been de-
scribed (Park et al., 2002) and might be expected to resemble
Cavin-knockout mice, their metabolic parameters have not
been determined.
In summary, the data presented here document that Cavin/
PTRF expression is an essential requirement in mammals for
the formation of caveolae in vivo in all tissues. Our results would
therefore suggest the need for a revised model to explain caveo-
lae structure and biogenesis because Cavin, and probably other
cytoplasmic and/or membrane proteins in addition to Cav1 or
Cav3, is absolutely necessary for the formation and/or stability
of caveolae. Our Cavin-deficient animals represent a model of
metabolic, adipocyte, and muscle dysfunction for exploring the
role of caveolae in a variety of physiological processes in vivo
and in vitro. They further suggest the possibility that the Cavin
gene locus may be a site of heretofore ungenotyped lipodystro-
phies present in the human population.
EXPERIMENTAL PROCEDURES
The details of western blot analysis (James et al., 1988), quantitative RT-PCR,
and transmission electronic microscope examination (Breton et al., 1998) are
described in the Supplemental Experimental Procedures.CeGeneration and Genotyping of Cavin-Knockout Mice
The Cavin-knockout mice were generated using a previously described strat-
egy (Yang et al., 2006). Briefly for the construction of the targeting vector,
mouse BAC clone bMQ-107C23 (derived from AB2.2 ES cells that are derived
from the 129S7 strain) containing the Cavin/Ptrf gene—which encodes the
Cavin protein—was obtained from TheWellcome Trust Sanger Institute (Cam-
bridge, UK). The targeting vector was constructed from the BAC clone using
a PCR strategy. Two 4 kb fragments from immediately upstream and down-
stream to the exon 1 region in Cavin gene (NCBI GenBank accession number
AF458959) were generated by PCR and subcloned into upstream and down-
stream of neomycin cassette (neo) in the pPNT targeting vector, respectively.
Then, a 3 kb fragment encoding prokaryotic b-gal (lacZ) from pcDNA3.1/
Hygro/lacZ vector (Invitrogen) was subcloned 50 of the neo cassette to
generate the final targeting vector.
The linearized targeting construct was electroporated into TC1 ES cells,
and incorporation of the vector by homologous recombination was selected
using G418 and FIAU. ES clones (200) were assessed for correct targeting
using PCR and Southern blot analysis. Genomic DNA was digested with
EcoRI or NdeI and hybridized with a 1.3 kb XbaI-XhoI probe spanning
promoter region.
Cavin+/ clones produced an 8.0 kb wild-type and a 5.3 kb knockout band.
Six correctly targeted clones were identified. Two were microinjected into
C57BL/6 blastocysts, and one gave rise to a female chimera with significant
ES cell contribution (as determined by Agouti coat color). By mating with
C57BL/6 males and genotyping the offspring by Southern blotting and PCR
analysis, germline transmission was confirmed (Figure 1). Male and female
heterozygous F1 animals were interbred to obtain Cavin-knockout (Cavin/)
animals. Genotypic verification by PCR is described in detail in the Supple-
mental Experimental Procedures.
Gender- and strain-matched (about 85% C57BL/6, as per
PCR-based gene-marker analysis MAX-BAX [Charles River Laboratories]) an-
imals were analyzed at about 6–8 weeks of age. Experiments were conducted
under the direct supervision of trained veterinarians of the Boston University
Laboratory Animal Science Center, and animal protocols were approved by
the Institutional Animal Care and Use Committee.
Body-Composition Analysis
Quantitative magnetic resonance was performed on 8-week-old wild-type (n =
6) and Cavin-knockout (n = 6) mice to directly measure total body fat and lean
mass (EchoMRI-900, EchoMedical Systems). Relative leanmass and fat mass
values were determined by dividing absolute values by body weight.
Metabolic Chamber Studies
Eight-week-old wild-type (n = 8) and Cavin-knockout (n = 8) mice were individ-
ually housed in metabolic chambers, and basal metabolic rate and habitual
physical activity were measured using a comprehensive laboratory animal-
monitoring system (Columbus Instruments). Basal metabolic rate (kcal/hr)
was derived from measures of oxygen consumption (VO2) and carbon dioxide
production (VCO2) by open-circuit indirect calorimetry. Horizontal or ambula-
tory physical activity was quantified by the number of infrared beams (emitted
by photocells) that were disrupted in the horizontal plane of the chambers.
Metabolic and activity data were first captured for 24 hr under fed conditions.
Then, food was removed from the chambers, and the animals were monitored
for another 24 hr under fasted conditions.
Analysis of Plasma Parameters
Mouse blood was drawn from the tail vein and decanted directly into heparin-
ized capillary tubes (Fisher Scientific). Triglyceride and free fatty acid levels
were measured with standard enzymatic colorimetric assays (Pointe Scien-
tific, Inc. and BioVision). Insulin and leptin levels were determined by ELISA
with kits (Alpco Diagnostics and GenWay, respectively). Adiponectin levels
were determined by quantitative immunoblotting with an anti-adiponectin an-
tibody (Affinity BioReagents), with the value for the wild-type mice set to 1.0.
Glucose Tolerance Test (GTT)
Wild-type (n = 8) andCavin-knockout (n = 8) mice were fasted overnight (12 hr),
weighed, and administered with 1 g/kg body weight of 20% D-glucose by
intraperitoneal-cavity injection. Tail-vein blood was collected before and atll Metabolism 8, 310–317, October 8, 2008 ª2008 Elsevier Inc. 315
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tration (Accu-Chek, Roche).
Statistical Analyses
We expressed data as arithmetic means ± SE and performed statistical anal-
ysis as indicated in the figure legends. Significant differences are indicated in
the figures.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and can
be found online at http://www.cellmetabolism.org/cgi/content/full/8/4/310/
DC1/.
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